Use of genetic instability to predict biochemical recurrence in intermediate-risk prostate cancer

被引：0
|
作者：
Bristow, R. G.
Ishkanian, A. S.
Malloff, C.
Milosevic, M.
Pintilie, M.
van der Kwast, T.
Lam, W.
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.42
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
42
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The risk of biochemical recurrence for intermediate-risk prostate cancer after radical prostatectomy
    Kurbegovic, Sorel
    Berg, Kasper Drimer
    Thomsen, Frederik Birkebaek
    Gruschy, Lisa
    Iversen, Peter
    Brasso, Klaus
    Roder, Martin Andreas
    SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 (06) : 450 - 456
  • [2] REASSESSMENT OF RISK FACTORS FOR BIOCHEMICAL RECURRENCE IN D'AMICO INTERMEDIATE-RISK PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY
    Narita, Shintaro
    Mitsuzuka, Koji
    Tsuchiya, Norihiko
    Koie, Takuya
    Kawamura, Sadafumi
    Ohyama, Chikara
    Tochigi, Tatsuo
    Yamaguchi, Takuhiro
    Arai, Yoichi
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2016, 195 (04): : E712 - E713
  • [3] TMPRSS2-ERG status and biochemical recurrence following radiotherapy for intermediate-risk prostate cancer
    Dal Pra, Alan
    Warde, Fiona
    Ishkanian, Adrian Shea
    Meng, Alice
    Malloff, Chad
    Lam, Wan
    Sykes, Jenna
    Pintile, Melania
    Squire, Jeremy
    van der Kwast, Theo
    Evans, Andrew
    Milosevic, Michael
    Bristow, Robert Glen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [4] Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer
    Kang, Ho Won
    Do Jung, Hae
    Lee, Joo Yong
    Kwon, Jong Kyou
    Jeh, Seong Uk
    Cho, Kang Su
    Ham, Won Sik
    Choi, Young Deuk
    ASIAN JOURNAL OF ANDROLOGY, 2016, 18 (03) : 480 - 484
  • [5] Evaluation of the UCSF cancer of the prostate risk assessment for prediction of biochemical recurrence (CAPRA) to predict which patients need dose escalation in intermediate-risk disease
    Taussky, Daniel
    Krishnan, Vimal
    Bahary, Jean-Paul
    Thu-Van Nguyen-Huynh
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [6] Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate-risk prostate cancer treated using radical prostatectomy
    Narita, Shintaro
    Mitsuzuka, Koji
    Tsuchiya, Norihiko
    Koie, Takuya
    Kawamura, Sadafumi
    Ohyama, Chikara
    Tochigi, Tatsuo
    Yamaguchi, Takuhiro
    Arai, Yoichi
    Habuchi, Tomonori
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (11) : 1029 - 1035
  • [7] Comparison of the Biochemical Recurrence Risk between Radical Prostatectomy and Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer
    Martinez, Pablo F.
    Belisle, Diego F.
    Cristallo, Christian
    Tobia, Ignacio
    Damia, Oscar
    Villamil, Wenceslao
    Giudice, Carlos R.
    ARCHIVOS ESPANOLES DE UROLOGIA, 2015, 68 (08): : 655 - 660
  • [8] Evaluation of the clinical use of PET/CT with 68Ga-PSMA for the assessment of biochemical recurrence of low or intermediate-risk prostate cancer
    Braga Ribeiro, Andre Marcondes
    Pereira Lima, Eduardo Nobrega
    Zequi, Stenio de Cassio
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (01) : 73.e9 - 73.e18
  • [9] Using PSA Kinetics to Predict 5-yr Biochemical Failure in Intermediate-Risk Prostate Cancer Patients
    McMullan, T.
    Nailon, B.
    McLaren, D.
    Keough, W.
    Law, A.
    Berger, T.
    Ronaldson, T.
    Mitchell, J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S193 - S194
  • [10] Biochemical Outcomes for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy
    Bryant, C. M.
    Mendenhall, W. M.
    Hoppe, B. S.
    Henderson, R. H.
    Nichols, R. C., Jr.
    Su, Z.
    Williams, C. R.
    Morris, C. G.
    Li, Z.
    Mendenhall, N. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E242 - E243
12345